688075.SH
安旭生物
SSE · Healthcare · Medical - Specialties · CN
CNY 29.08
−1.59%Sep 1, 2026, 12:36 UTC
Anxu Bio announced that as of August 31, 2026, it had repurchased 707,939 shares (0.5571% of total shares) for a total of 25.3445 million yuan under its ongoing buyback program.
Source:Aug 27, 2026, 11:25 UTC
Anxu Bio reported a net loss of 10.6413 million yuan for the first half of 2026, turning from a profit in the same period last year.
Source: